Today: 30 April 2026

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Applied Materials (AMAT) Stock Hits Record Highs on AI Chip Boom – Latest News, Analyst Targets and Forecasts as of December 3, 2025

Applied Materials (AMAT) Stock Hits Record Highs on AI Chip Boom – Latest News, Analyst Targets and Forecasts as of December 3, 2025

Applied Materials shares hit a record near $267 on December 3, up over 60% in 2025 as investors bet on AI chip demand. The stock closed at $265.33 on December 2, with a market cap around $211 billion. Analysts rate AMAT a “Moderate Buy,” but the average 12-month price target sits below current levels. Institutional ownership stands at about 80.5%.
Nebius Group N.V. (NBIS) Stock: 2025 AI Moonshot, Microsoft and Meta Mega-Deals, and 2026 Forecast as of December 3, 2025

Nebius Group N.V. (NBIS) Stock: 2025 AI Moonshot, Microsoft and Meta Mega-Deals, and 2026 Forecast as of December 3, 2025

Nebius Group shares traded around $97.38 midday on December 3, up about 248% year-to-date but down 30% from October highs. The company, spun off from Yandex and now focused on AI cloud infrastructure, holds a market cap near $24.5 billion. Q3 net income was –$119.6 million. Data centers operate in the U.S. and Europe, with Nvidia as a key partner.
Bristol-Myers Squibb (BMY) Stock Surges on Cobenfy Trial Twist and AI Milestone: Full Outlook as of December 3, 2025

Bristol-Myers Squibb (BMY) Stock Surges on Cobenfy Trial Twist and AI Milestone: Full Outlook as of December 3, 2025

Bristol-Myers Squibb shares jumped over 6% to $51.32 intraday on December 3, 2025, after the company announced a data review and patient re-enrollment for its ADEPT-2 Alzheimer’s psychosis trial. The stock rally follows strong Q3 results and analyst upgrades, despite ongoing legal risks and looming patent expiries.
Exxon Mobil (XOM) Stock Today: UBS $145 Target, West Qurna Talks and 2026 Oil Glut Fears – December 3, 2025 Update

Exxon Mobil (XOM) Stock Today: UBS $145 Target, West Qurna Talks and 2026 Oil Glut Fears – December 3, 2025 Update

Exxon Mobil traded near $117.9 per share intraday on December 3, 2025, up 2.2%, with a market cap just under $490 billion. UBS initiated coverage with a “Buy” rating and $145 target, joining other bullish brokerages. The stock sits close to its 52-week high of $120.81. Institutional investors have increased positions, while analysts debate Exxon’s prospects amid warnings of lower crude prices by 2026.
3 December 2025
DoorDash (DASH) Stock Rallies as $100 Million Insider Bet and Analyst Upgrades Clash With Amazon’s 30‑Minute Delivery Push

DoorDash (DASH) Stock Rallies as $100 Million Insider Bet and Analyst Upgrades Clash With Amazon’s 30‑Minute Delivery Push

DoorDash shares traded around $222 Wednesday afternoon, up sharply from November lows but still 20% below October’s peak. The stock briefly jumped over 3% intraday after renewed analyst optimism and heavy insider buying, following a volatile month of earnings-driven swings, regulatory headlines, and Amazon’s new ultra-fast delivery test. Market value hovered near $94 billion.
3 December 2025
Circle Internet Group (CRCL) Stock Outlook on December 3, 2025: Price Action, Analyst Ratings and 2026 Forecast

Circle Internet Group (CRCL) Stock Outlook on December 3, 2025: Price Action, Analyst Ratings and 2026 Forecast

Circle Internet Group (NYSE: CRCL) closed at $84.14 on Dec. 3, up 8.65% after Japanese regulatory news, with 14.6 million shares traded. The stock remains far below its late-June peak of $298.99, despite rebounding from November lows in the low $70s. Wall Street analysts are split, with a consensus “Hold” and a 12-month price target averaging $144.69. Circle went public in June 2025, raising $1.05 billion.
3 December 2025
AppLovin (APP) Stock Jumps on AI Adtech Momentum Despite SEC Probe – Latest News & Forecasts as of December 3, 2025

AppLovin (APP) Stock Jumps on AI Adtech Momentum Despite SEC Probe – Latest News & Forecasts as of December 3, 2025

AppLovin shares traded near $665 Wednesday, up 1–2% and close to recent highs, with a market cap around $220 billion. Q3 revenue rose 68% to $1.41 billion, net income jumped over 90% to $836 million, and the company boosted its share repurchase plan by $3.2 billion. The SEC is investigating AppLovin’s data practices amid heavy insider selling. Analyst consensus remains “Strong Buy.”
CoreWeave (CRWV) Stock After a 45% November Crash: Latest News, Analyst Forecasts and AI Cloud Outlook as of December 3, 2025

CoreWeave (CRWV) Stock After a 45% November Crash: Latest News, Analyst Forecasts and AI Cloud Outlook as of December 3, 2025

CoreWeave shares closed near $77 on December 3, up 1–2% for the day but down about 60% from a June peak of $187. The Nvidia-backed AI cloud provider cut its 2025 revenue outlook last month, citing delayed capacity from a partner. The stock remains nearly double its $40 March IPO price. CoreWeave operates 32 data centers with about 250,000 GPUs.
Uber Stock (UBER) on December 3, 2025: Robotaxis, Buybacks and $125 Targets – What Investors Need to Know Now

Uber Stock (UBER) on December 3, 2025: Robotaxis, Buybacks and $125 Targets – What Investors Need to Know Now

Uber shares rose about 4% to just under $91 Wednesday after launching robotaxis in Dallas and receiving a Wall Street upgrade with a $125 price target. The company’s market cap stands near $188 billion. Uber hit an all-time high of $100.10 in October but remains below that level. Its trailing P/E is around 11, boosted by recent one-time gains.
Boeing (BA) Stock Today: Spirit AeroSystems Ruling, Cash-Flow Pledge and Airbus Troubles Move the Share Price – December 3, 2025

Boeing (BA) Stock Today: Spirit AeroSystems Ruling, Cash-Flow Pledge and Airbus Troubles Move the Share Price – December 3, 2025

Boeing shares fell about 3% intraday Wednesday after the FTC approved its $8.3 billion Spirit AeroSystems takeover, requiring Boeing to divest key Spirit assets that supply Airbus and U.S. defense programs. The stock traded near $200 after Tuesday’s 10% surge, as investors reacted to the deal’s conditions and recent upbeat cash-flow guidance.
Pure Storage (PSTG) Stock Plunges After Q3 Earnings: What December’s Sell-Off Means for the AI Storage Leader

Pure Storage (PSTG) Stock Plunges After Q3 Earnings: What December’s Sell-Off Means for the AI Storage Leader

Pure Storage shares plunged 26% to around $70 on December 3, 2025, despite reporting strong Q3 results and raising full-year guidance. Net income fell to $54.8 million from $63.6 million a year earlier as higher spending cut into profits. The stock had recently hit a 52-week high above $100, leaving it vulnerable to concerns over margins and increased investment.
Walmart Stock Nears $900 Billion Valuation: What December 3, 2025 Means for WMT Investors

Walmart Stock Nears $900 Billion Valuation: What December 3, 2025 Means for WMT Investors

Walmart shares hit $113–114 on December 3, 2025, near record highs and up about 25% year to date. The company’s market capitalization hovered around $900 billion, briefly topping $906 billion, making Walmart one of the world’s most valuable firms. Trading volume was heavy as the stock set new 52-week highs this week. Walmart now trades at roughly 40 times earnings, far above most retail peers.
3 December 2025
Salesforce (CRM) Stock on December 3, 2025: Earnings Preview, Analyst Targets and AI-Driven Outlook

Salesforce (CRM) Stock on December 3, 2025: Earnings Preview, Analyst Targets and AI-Driven Outlook

Salesforce shares traded near $237 midday December 3, up slightly but down almost 30% for 2025. The company reports third-quarter fiscal 2026 earnings after the bell, with Wall Street watching for signs its AI investments are driving growth. Options markets signal a possible 7% swing in the stock by week’s end. Analyst price targets remain well above current levels.
Capricor Therapeutics (CAPR) Stock Skyrockets on HOPE‑3 Win: FDA Path, Price Targets and 2026 Outlook

Capricor Therapeutics (CAPR) Stock Skyrockets on HOPE‑3 Win: FDA Path, Price Targets and 2026 Outlook

Capricor Therapeutics shares jumped over 380% Wednesday after reporting positive Phase 3 HOPE-3 trial results for deramiocel in Duchenne muscular dystrophy. The stock opened near $30, up from $6.36, hitting intraday highs around $40 on volume over 40 million shares. The FDA previously rejected deramiocel but will review new data for possible approval in 2026. Capricor ended Q3 with $98.6 million in cash.
1 719 720 721 722 723 764

Stock Market Today

  • Investors Advised to Follow Fed Chair Powell's Cautious Stance on Iran War Impact
    April 29, 2026, 9:10 PM EDT. Federal Reserve Chair Jerome Powell, in his final meeting, kept the Fed funds rate unchanged, emphasizing patience amid the Middle East conflict's uncertainty. Powell highlighted the war in Iran as a factor affecting inflation but cautioned against making premature policy moves. He urged investors to recognize the unpredictability of the conflict's course and impact on energy prices. The stock market's rebound after initial sell-offs linked to the war suggests a need for measured responses rather than abrupt portfolio changes. Powell's approach underlines the importance of long-term investing amidst geopolitical tensions, as markets historically recover from crises, including wars and economic downturns. Investors are advised to monitor but not overreact to volatile wartime developments.

Latest article

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

30 April 2026
Soluna Holdings filed to register the resale of about 2.46 million common shares, with no proceeds going to the company. The move follows Sazmining’s launch of a 3-megawatt Bitcoin mining operation at Soluna’s Project Dorothy 1B in West Texas. Soluna shares last traded at $1.28, up from a $1.08 Nasdaq sale price on April 28. The registered shares include 2.4 million issuable to YA II PN, LTD. via warrant exercise.
Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

30 April 2026
Brookfield Renewable Corp’s NYSE shares fell 12.5% to $35.20 on Wednesday, with volume quadrupling the three-month average ahead of first-quarter results due Friday. The drop came despite a higher quarterly dividend and mixed analyst views. The company operates 47 GW of clean energy assets globally. Analysts expect a first-quarter loss of 33.92 cents per share on $1.62 billion in revenue.
Go toTop